Status:
COMPLETED
Blue Light in the Treatment of Inflammatory Skin Diseases
Lead Sponsor:
Medical University of Lodz
Conditions:
Atopic Dermatitis
Psoriasis Vulgaris
Eligibility:
All Genders
8+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to assess the effectiveness of full-body blue light irradiations in the treatment of inflammatory skin diseases (atopic dermatitis, psoriasis, eczema) and chronic pr...
Detailed Description
After giving written, informed consent, skin examination will be performed (including photo documentation) and each patient will have skin phototype assessed according to Fitzpatrick's scale. A detail...
Eligibility Criteria
Inclusion
- Informed consent to participate in a medical experiment
- Age above 8 years of age
- Diagnosis of psoriasis / eczema / atopic dermatitis
- Chronic pruritus (lasting more than 6 weeks)
- Good general health (no history of other clinically significant diseases according to the doctor's assessment)
- A patient who is able to understand the information related to the experiment, meet the requirements contained in the protocol of the experiment, who undertakes to strictly follow medical recommendations and appear on time for visits.
Exclusion
- Patients with known hypersensitivity to ultraviolet or blue radiation
- Age under 8 years of age
- Women who are pregnant, breastfeeding or planning to become pregnant during the experiment
- Patients who participated in another experiment / clinical trial within 30 days prior to inclusion in the experiment
- Patients unwilling or unable to respect the requirements of the experiment
- Patients with skin diseases other than inflammatory skin diseases or chronic pruritus
- Planned hospitalizations or surgical procedures during the medical experiment
- Patients using medications with proven phototoxic effect
- Diastolic blood pressure\> 95mmHg and \<65mmHg
- Patients with congenital or acquired immune disorders
- Patients with a history or at the time of the examination diagnosed with a malignant skin cancer, severe actinic keratosis or dysplastic moles
- Patients diagnosed with genophotodermatosis, increasing the risk of skin cancers, including xeroderma pigmentosum, Cockayne's syndrome, Bloom's syndrome)
- Patients addicted to alcohol / drugs in the last 12 months
Key Trial Info
Start Date :
November 27 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 25 2022
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT06516783
Start Date
November 27 2020
End Date
November 25 2022
Last Update
July 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Dermatology, Pediatric Dermatology and Dermatological Oncology, Medical University of Lodz
Lodz, Poland